Possible changes in the standard of care for prostate cancer
Addition of abiraterone acetate plus prednisone shows clear survival improvements in castration-sensitive prostate cancer studies report at ESMO 2021
Addition of abiraterone acetate plus prednisone shows clear survival improvements in castration-sensitive prostate cancer studies report at ESMO 2021
Clinical trials have an impact on the environment, and novel approaches may help researchers reshape their activities toward a greater sustainability
The abstract submission system is now open
Merkel-cell carcinoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Prof. Julien Taieb comments on the major advances from colorectal cancer research which are driving the development of molecular-based therapies
Registration is now open
The EHDS can contribute to boosting cancer research by facilitating the (re)use of existing data sources – in anonymised or pseudorandomised format
The Medical Oncology Course for Students will take place in Naples and Valencia in 2019